Structure Therapeutics (GPCR) Common Equity (2022 - 2026)
Structure Therapeutics' Common Equity was $1.35 billion in Q2 2026, up 75.4% from $772.08 million a year earlier but down 6.4% from the prior quarter.
Powered by 
Analysis
Structure Therapeutics (GPCR) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Structure Therapeutics came in at $1.52 billion, up 75.3% from FY2024.
- In earlier years, Common Equity was $864.84 million in FY2024 (+90.9%), $452.97 million in FY2023 and -$115.14 million in FY2022.
- Quarterly Common Equity has moved between -$115.14 million (Q4 2022) and $1.52 billion (Q4 2025) over five years.
- Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 92.9% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q3 2024 (growth of 364.8%); the worst was Q2 2025 (a decline of 16.2%).
- Per Business Quant data, GPCR's Common Equity in the three quarters before Q2 2026 was $1.45 billion (Q1 2026), $1.52 billion (Q4 2025) and $770.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Structure Therapeutics | 7.49 Bn | 7.49 Bn | - | 1.35 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Bn |
| Mar 31, 2026 | 1.45 Bn |
| Dec 31, 2025 | 1.52 Bn |
| Sep 30, 2025 | 770.02 Mn |
| Jun 30, 2025 | 772.08 Mn |
| Mar 31, 2025 | 824.64 Mn |
| Dec 31, 2024 | 864.84 Mn |
| Sep 30, 2024 | 896.80 Mn |
| Jun 30, 2024 | 921.03 Mn |
| Mar 31, 2024 | 429.82 Mn |
| Dec 31, 2023 | 452.97 Mn |
| Sep 30, 2023 | 192.96 Mn |
| Jun 30, 2023 | 214.42 Mn |
| Mar 31, 2023 | 236.35 Mn |
| Dec 31, 2022 | -115.14 Mn |
| Sep 30, 2022 | -103.91 Mn |
| Jun 30, 2022 | -92.10 Mn |
| Mar 31, 2022 | -77.23 Mn |
API Access
Structure Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();